‘modest’

AstraZeneca set for ‘modest’ profit from sold COVID-19 vaccines-

By PTI LONDON: AstraZeneca, the UK-headquartered biopharmaceutical company behind the manufacture of the Oxford University developed COVID-19 vaccine, said on ...